MHRA recalls Sertraline 100mg batch over packaging error
→Pharmacy teams must stop dispensing Sertraline batch V2500425 immediately
Change
UK's MHRA ordered an immediate recall of Sertraline 100mg batch V2500425 after a packaging error mixed in Citalopram 40mg tablets.
Why it matters
Affected packs may contain Citalopram 40mg blister strips instead of Sertraline. Pharmacies must remove the batch from circulation, contact patients dispensed the product and coordinate prescription review with the GP or responsible clinician.
Implications
- → Pharmacy dispensing teams must stop supplying batch V2500425 immediately — continued dispensing breaches MHRA instruction
- → Pharmacy stock-control teams must quarantine and return all affected stock — retained inventory risks accidental use
- → Pharmacists must contact affected patients and arrange returns — missed outreach risks continued patient exposure
Full decision brief
Unlock the decision layer.
Get the implications, affected teams, what to watch, and Clarify with AI — so the change becomes easier to act on.
Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you
Source
View on UK Government